8-KEarnings & ResultsRegulation FDExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Feb 5, 2026)

Filed February 5, 2026For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) has filed an 8-K report on February 5, 2026, to announce its financial results for the fourth quarter and full year of 2025. The filing includes a press release (Exhibit 99.1) detailing these results and a presentation (Exhibit 99.2) covering financial and operating initiatives. Investors should refer to these documents, available on the company's website, for a comprehensive understanding of BMY's recent performance and strategic direction. Both the press release and presentation reference non-GAAP financial information. The company emphasizes that reconciliations between non-GAAP and GAAP measures, along with explanations for the use of non-GAAP figures, are provided within the press release. Investors are advised to review these reconciliations carefully when evaluating the company's financial health and operational efficiency.

Key Highlights

  • 1BMY announced its Q4 2025 and full-year 2025 financial results via an earnings press release filed on February 5, 2026.
  • 2A supplementary presentation on financial and operating initiatives is also available and furnished as part of this filing.
  • 3Both the earnings release and presentation were made available on the company's website (www.bms.com).
  • 4The company's conference call and webcast to discuss these results occurred on February 5, 2026, at 8:00 a.m. Eastern time.
  • 5Key financial and operational performance data for Q4 and FY 2025 are detailed in the provided press release and presentation.
  • 6Both documents contain non-GAAP financial information, with reconciliations to GAAP measures provided in the earnings press release.

Frequently Asked Questions

The detailed financial results are available in the Earnings Press Release (Exhibit 99.1) and the Bristol Myers Presentation (Exhibit 99.2) furnished with this 8-K filing. Both documents can be accessed on Bristol-Myers Squibb's website at www.bms.com.

The filing indicates that both the Earnings Press Release and the Bristol Myers Presentation include non-GAAP financial information. These measures are often used to provide a clearer view of ongoing operational performance by excluding certain items. Reconciliations between these non-GAAP measures and the comparable GAAP financial measures, along with the rationale for their use, are detailed in the Earnings Press Release (Exhibit 99.1).

Bristol-Myers Squibb Company announced its financial results for the fourth quarter and full year of 2025 on February 5, 2026, via a press release and a webcast.